調査レポート | • レポートコード：GIR-2104Z10425 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、店頭（OTC）薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。店頭（OTC）薬の種類別市場規模（風邪・インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・店頭（OTC）薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Boehringer Ingelheim、GSK、Novartis、Pfizer、PGT healthcare、Sanofi、Teva Pharmaceuticals、Takeda、Cipla、Sun Pharmaceutical Industries、Glenmark、Innovus Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：風邪・インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・店頭（OTC）薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・店頭（OTC）薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・店頭（OTC）薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・店頭（OTC）薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・店頭（OTC）薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Over-The-Counter (OTC) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Over-The-Counter (OTC) Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Over-The-Counter (OTC) Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Over-The-Counter (OTC) Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cold and Flu Products
Analgesics
Dermatological Products
Gastrointestinal Products
Vitamin
Other
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
The key market players for global Over-The-Counter (OTC) Drugs market are listed below:
Bayer
Boehringer Ingelheim
GSK
Novartis
Pfizer
PGT healthcare
Sanofi
Teva Pharmaceuticals
Takeda
Cipla
Sun Pharmaceutical Industries
Glenmark
Innovus Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Over-The-Counter (OTC) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Over-The-Counter (OTC) Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Cold and Flu Products
1.2.3 Analgesics
1.2.4 Dermatological Products
1.2.5 Gastrointestinal Products
1.2.6 Vitamin
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Over-The-Counter (OTC) Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Over-The-Counter (OTC) Drugs Market Size & Forecast
1.4.1 Global Over-The-Counter (OTC) Drugs Sales in Value (2016-2026))
1.4.2 Global Over-The-Counter (OTC) Drugs Sales in Volume (2016-2026)
1.4.3 Global Over-The-Counter (OTC) Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Over-The-Counter (OTC) Drugs Production Capacity Analysis
1.5.1 Global Over-The-Counter (OTC) Drugs Total Production Capacity (2016-2026)
1.5.2 Global Over-The-Counter (OTC) Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Over-The-Counter (OTC) Drugs Market Drivers
1.6.2 Over-The-Counter (OTC) Drugs Market Restraints
1.6.3 Over-The-Counter (OTC) Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Over-The-Counter (OTC) Drugs Product and Services
2.1.4 Bayer Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product and Services
2.2.4 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Over-The-Counter (OTC) Drugs Product and Services
2.3.4 GSK Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Over-The-Counter (OTC) Drugs Product and Services
2.4.4 Novartis Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Over-The-Counter (OTC) Drugs Product and Services
2.5.4 Pfizer Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 PGT healthcare
2.6.1 PGT healthcare Details
2.6.2 PGT healthcare Major Business
2.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Product and Services
2.6.4 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Over-The-Counter (OTC) Drugs Product and Services
2.7.4 Sanofi Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Teva Pharmaceuticals
2.8.1 Teva Pharmaceuticals Details
2.8.2 Teva Pharmaceuticals Major Business
2.8.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product and Services
2.8.4 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Over-The-Counter (OTC) Drugs Product and Services
2.9.4 Takeda Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Cipla
2.10.1 Cipla Details
2.10.2 Cipla Major Business
2.10.3 Cipla Over-The-Counter (OTC) Drugs Product and Services
2.10.4 Cipla Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Sun Pharmaceutical Industries
2.11.1 Sun Pharmaceutical Industries Details
2.11.2 Sun Pharmaceutical Industries Major Business
2.11.3 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product and Services
2.11.4 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Glenmark
2.12.1 Glenmark Details
2.12.2 Glenmark Major Business
2.12.3 Glenmark Over-The-Counter (OTC) Drugs Product and Services
2.12.4 Glenmark Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Innovus Pharmaceuticals
2.13.1 Innovus Pharmaceuticals Details
2.13.2 Innovus Pharmaceuticals Major Business
2.13.3 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product and Services
2.13.4 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Over-The-Counter (OTC) Drugs Sales by Manufacturer
3.1 Global Over-The-Counter (OTC) Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Over-The-Counter (OTC) Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Over-The-Counter (OTC) Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Over-The-Counter (OTC) Drugs Manufacturer Market Share
3.4.2 Top 6 Over-The-Counter (OTC) Drugs Manufacturer Market Share
3.5 Global Over-The-Counter (OTC) Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Over-The-Counter (OTC) Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Over-The-Counter (OTC) Drugs Market Size by Region
4.1.1 Global Over-The-Counter (OTC) Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Over-The-Counter (OTC) Drugs Revenue by Region (2016-2026)
4.2 North America Over-The-Counter (OTC) Drugs Revenue (2016-2026)
4.3 Europe Over-The-Counter (OTC) Drugs Revenue (2016-2026)
4.4 Asia-Pacific Over-The-Counter (OTC) Drugs Revenue (2016-2026)
4.5 South America Over-The-Counter (OTC) Drugs Revenue (2016-2026)
4.6 Middle East and Africa Over-The-Counter (OTC) Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Over-The-Counter (OTC) Drugs Sales in Volume by Type (2016-2026)
5.2 Global Over-The-Counter (OTC) Drugs Revenue by Type (2016-2026)
5.3 Global Over-The-Counter (OTC) Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Over-The-Counter (OTC) Drugs Sales in Volume by Application (2016-2026)
6.2 Global Over-The-Counter (OTC) Drugs Revenue by Application (2016-2026)
6.3 Global Over-The-Counter (OTC) Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Over-The-Counter (OTC) Drugs Sales by Type (2016-2026)
7.2 North America Over-The-Counter (OTC) Drugs Sales by Application (2016-2026)
7.3 North America Over-The-Counter (OTC) Drugs Market Size by Country
7.3.1 North America Over-The-Counter (OTC) Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Over-The-Counter (OTC) Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Over-The-Counter (OTC) Drugs Sales by Type (2016-2026)
8.2 Europe Over-The-Counter (OTC) Drugs Sales by Application (2016-2026)
8.3 Europe Over-The-Counter (OTC) Drugs Market Size by Country
8.3.1 Europe Over-The-Counter (OTC) Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Over-The-Counter (OTC) Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Over-The-Counter (OTC) Drugs Market Size by Region
9.3.1 Asia-Pacific Over-The-Counter (OTC) Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Over-The-Counter (OTC) Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Over-The-Counter (OTC) Drugs Sales by Type (2016-2026)
10.2 South America Over-The-Counter (OTC) Drugs Sales by Application (2016-2026)
10.3 South America Over-The-Counter (OTC) Drugs Market Size by Country
10.3.1 South America Over-The-Counter (OTC) Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Over-The-Counter (OTC) Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Over-The-Counter (OTC) Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Over-The-Counter (OTC) Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Over-The-Counter (OTC) Drugs Market Size by Country
11.3.1 Middle East & Africa Over-The-Counter (OTC) Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Over-The-Counter (OTC) Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Over-The-Counter (OTC) Drugs Typical Distributors
12.3 Over-The-Counter (OTC) Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Over-The-Counter (OTC) Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Over-The-Counter (OTC) Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Over-The-Counter (OTC) Drugs Product and Services
Table 6. Bayer Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Major Business
Table 9. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product and Services
Table 10. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Over-The-Counter (OTC) Drugs Product and Services
Table 14. GSK Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Over-The-Counter (OTC) Drugs Product and Services
Table 18. Novartis Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Over-The-Counter (OTC) Drugs Product and Services
Table 22. Pfizer Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. PGT healthcare Basic Information, Manufacturing Base and Competitors
Table 24. PGT healthcare Major Business
Table 25. PGT healthcare Over-The-Counter (OTC) Drugs Product and Services
Table 26. PGT healthcare Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Over-The-Counter (OTC) Drugs Product and Services
Table 30. Sanofi Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceuticals Major Business
Table 33. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product and Services
Table 34. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Takeda Basic Information, Manufacturing Base and Competitors
Table 36. Takeda Major Business
Table 37. Takeda Over-The-Counter (OTC) Drugs Product and Services
Table 38. Takeda Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cipla Basic Information, Manufacturing Base and Competitors
Table 40. Cipla Major Business
Table 41. Cipla Over-The-Counter (OTC) Drugs Product and Services
Table 42. Cipla Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Industries Major Business
Table 45. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product and Services
Table 46. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Glenmark Basic Information, Manufacturing Base and Competitors
Table 48. Glenmark Major Business
Table 49. Glenmark Over-The-Counter (OTC) Drugs Product and Services
Table 50. Glenmark Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Innovus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Innovus Pharmaceuticals Major Business
Table 53. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product and Services
Table 54. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Over-The-Counter (OTC) Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Over-The-Counter (OTC) Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Over-The-Counter (OTC) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Over-The-Counter (OTC) Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Over-The-Counter (OTC) Drugs Production Site of Key Manufacturer
Table 60. Global Over-The-Counter (OTC) Drugs Sales by Region (2016-2021e) & (K Units)
Table 61. Global Over-The-Counter (OTC) Drugs Sales by Region (2021-2026) & (K Units)
Table 62. Global Over-The-Counter (OTC) Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Over-The-Counter (OTC) Drugs Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Over-The-Counter (OTC) Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. Global Over-The-Counter (OTC) Drugs Sales by Type (2021-2026) & (K Units)
Table 66. Global Over-The-Counter (OTC) Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Over-The-Counter (OTC) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Over-The-Counter (OTC) Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 69. Global Over-The-Counter (OTC) Drugs Price by Type (2021-2026) & (USD/Unit)
Table 70. Global Over-The-Counter (OTC) Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. Global Over-The-Counter (OTC) Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Global Over-The-Counter (OTC) Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Over-The-Counter (OTC) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Over-The-Counter (OTC) Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 75. Global Over-The-Counter (OTC) Drugs Price by Application (2021-2026) & (USD/Unit)
Table 76. North America Over-The-Counter (OTC) Drugs Sales by Country (2016-2021e) & (K Units)
Table 77. North America Over-The-Counter (OTC) Drugs Sales by Country (2021-2026) & (K Units)
Table 78. North America Over-The-Counter (OTC) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Over-The-Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Over-The-Counter (OTC) Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. North America Over-The-Counter (OTC) Drugs Sales by Type (2021-2026) & (K Units)
Table 82. North America Over-The-Counter (OTC) Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. North America Over-The-Counter (OTC) Drugs Sales by Application (2021-2026) & (K Units)
Table 84. Europe Over-The-Counter (OTC) Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. Europe Over-The-Counter (OTC) Drugs Sales by Country (2021-2026) & (K Units)
Table 86. Europe Over-The-Counter (OTC) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Over-The-Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Over-The-Counter (OTC) Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. Europe Over-The-Counter (OTC) Drugs Sales by Type (2021-2026) & (K Units)
Table 90. Europe Over-The-Counter (OTC) Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. Europe Over-The-Counter (OTC) Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Region (2016-2021e) & (K Units)
Table 93. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Region (2021-2026) & (K Units)
Table 94. Asia-Pacific Over-The-Counter (OTC) Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Over-The-Counter (OTC) Drugs Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Application (2021-2026) & (K Units)
Table 100. South America Over-The-Counter (OTC) Drugs Sales by Country (2016-2021e) & (K Units)
Table 101. South America Over-The-Counter (OTC) Drugs Sales by Country (2021-2026) & (K Units)
Table 102. South America Over-The-Counter (OTC) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Over-The-Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Over-The-Counter (OTC) Drugs Sales by Type (2016-2021e) & (K Units)
Table 105. South America Over-The-Counter (OTC) Drugs Sales by Type (2021-2026) & (K Units)
Table 106. South America Over-The-Counter (OTC) Drugs Sales by Application (2016-2021e) & (K Units)
Table 107. South America Over-The-Counter (OTC) Drugs Sales by Application (2021-2026) & (K Units)
Table 108. Middle East & Africa Over-The-Counter (OTC) Drugs Sales by Country (2016-2021e) & (K Units)
Table 109. Middle East & Africa Over-The-Counter (OTC) Drugs Sales by Country (2021-2026) & (K Units)
Table 110. Middle East & Africa Over-The-Counter (OTC) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Over-The-Counter (OTC) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Over-The-Counter (OTC) Drugs Sales by Type (2016-2021e) & (K Units)
Table 113. Middle East & Africa Over-The-Counter (OTC) Drugs Sales by Type (2021-2026) & (K Units)
Table 114. Middle East & Africa Over-The-Counter (OTC) Drugs Sales by Application (2016-2021e) & (K Units)
Table 115. Middle East & Africa Over-The-Counter (OTC) Drugs Sales by Application (2021-2026) & (K Units)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Over-The-Counter (OTC) Drugs Typical Distributors
Table 119. Over-The-Counter (OTC) Drugs Typical Customers
List of Figures
Figure 1. Over-The-Counter (OTC) Drugs Picture
Figure 2. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2020
Figure 3. Cold and Flu Products
Figure 4. Analgesics
Figure 5. Dermatological Products
Figure 6. Gastrointestinal Products
Figure 7. Vitamin
Figure 8. Other
Figure 9. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2020
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Online Pharmacy
Figure 13. Global Over-The-Counter (OTC) Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Over-The-Counter (OTC) Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. United States Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Canada Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Mexico Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Germany Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. France Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. United Kingdom Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Russia Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Italy Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. China Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Japan Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Korea Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. India Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Southeast Asia Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Australia Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Brazil Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Egypt Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Saudi Arabia Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. South Africa Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Turkey Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Global Over-The-Counter (OTC) Drugs Sales (2016-2026) & (K Units)
Figure 35. Global Over-The-Counter (OTC) Drugs Production Capacity (2016-2026) & (K Units)
Figure 36. Global Over-The-Counter (OTC) Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 37. Over-The-Counter (OTC) Drugs Market Drivers
Figure 38. Over-The-Counter (OTC) Drugs Market Restraints
Figure 39. Over-The-Counter (OTC) Drugs Market Trends
Figure 40. Global Over-The-Counter (OTC) Drugs Sales Market Share by Manufacturer in 2020
Figure 41. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Manufacturer in 2020
Figure 42. Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 43. Top 3 Over-The-Counter (OTC) Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Top 6 Over-The-Counter (OTC) Drugs Manufacturer (Revenue) Market Share in 2020
Figure 45. Global Over-The-Counter (OTC) Drugs Sales Market Share by Region (2016-2026)
Figure 46. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2016-2026)
Figure 47. North America Over-The-Counter (OTC) Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Europe Over-The-Counter (OTC) Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Over-The-Counter (OTC) Drugs Revenue (2016-2026) & (USD Million)
Figure 50. South America Over-The-Counter (OTC) Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Middle East & Africa Over-The-Counter (OTC) Drugs Revenue (2016-2026) & (USD Million)
Figure 52. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 53. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Type (2016-2026)
Figure 54. Global Over-The-Counter (OTC) Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 55. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 56. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Application (2016-2026)
Figure 57. Global Over-The-Counter (OTC) Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 58. North America Over-The-Counter (OTC) Drugs Sales Market Share by Country (2016-2026)
Figure 59. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 60. North America Over-The-Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 61. North America Over-The-Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 62. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Country (2016-2026)
Figure 63. Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 64. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 65. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 70. South America Over-The-Counter (OTC) Drugs Sales Market Share by Country (2016-2026)
Figure 71. South America Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 72. South America Over-The-Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 73. South America Over-The-Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Over-The-Counter (OTC) Drugs Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Over-The-Counter (OTC) Drugs Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Over-The-Counter (OTC) Drugs Sales Market Share by Application (2016-2026)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の店頭薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Over-the-Counter Drugs Market The global Over-the-Counter Drugs market size is projected to reach US$ 48120 million by 2026, from US$ 42530 million in 2019, at a CAGR of 1.8% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, t…- 世界の店頭デリバティブ（OTC）＆ダイエットサプリメント市場 2021：企業別、地域別、種類・用途別 The Over the Counter (OTC) & Diet Supplementary market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 世界の市販鎮痛薬市場規模・現状・予測（2021年-2027年） Over-the-counter pain medication are very helpful for the person suffering from minor and major pain. As the over-the-counter are easily available without proper prescriptions and very effective to control the pain. Over-the-counter pain medication are approved product from the regulatory authority,…
- 世界の市販鎮痛薬市場規模・現状・予測（2021年-2027年） Over-the-counter pain medication are very helpful for the person suffering from minor and major pain. As the over-the-counter are easily available without proper prescriptions and very effective to control the pain. Over-the-counter pain medication are approved product from the regulatory authority,…
- 世界のカウンターUAV市場規模・現状・予測（2021年-2027年） Counter-drone technology, also known as counter-UAS, C-UAS, or counter-UAV technology, refers to systems that are used to detect and/or intercept unmanned aircraft. As concerns grow around the potential security threats drones may pose to both civilian and military entities, a new market for counter…